Article Details
Retrieved on: 2023-01-13 17:06:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Enrollment for the randomization phase of SPLASH completed prior to EOY 2022, meeting previous guidance. INDIANAPOLIS — POINT Biopharma Global Inc., a ...
Article found on: www.canadianmanufacturing.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here